Basal cell carcinoma (BCC) presents with diverse clinical features, and several morphologic and histologic variants of BCC have been reported [Sexton et al.: J Am Acad Dermatol 1990;23:1118-1126. Linear BCC was first described as a new clinical subtype in 1985 by Lewis [Int J Dematol 1985;24:124-125]. Here, we present a case of linear BCC that we recently encountered in an elderly Japanese patient, and review other cases reported in Japan.
She presented with a small, black nodule on the lateral side of her lower eyelid and another small, black nodule on the inner canthus. A linear lesion, 3 × 20 mm in size, was seen extending from the right lateral to the medial infraorbital crease, with a scar-like appearance ( fig. 1) . Dermatoscopic examination revealed arborizing vessels, multiple blue-gray globules and large, blue-gray ovoid nests ( fig. 2) . Laboratory tests showed no abnormalities in hematological parameters, and both family history and personal medical history were unremarkable.
The tumor region was completely excised with a 3-mm margin. Histologically, in the 2 nodules, nests of atypical cells resembling epidermal basal cells were present in the dermis, and some of the nests were contiguous with the epidermis. In the lateral nodule, the nests mainly appeared in a nodular arrangement, while in the median nodule, infiltrative arrangement was mainly noted. Subsequently, basal cell carcinoma (BCC), nodular type in the lateral lesion and infiltrative type in the median lesion, was diagnosed. In the linear area between the 2 nodules, the presence of BCC nests was sporadically noted, thus the typing of BCC was not performed in that area ( fig. 3, fig. 4 ). On the basis of these clinical and histopathological findings, namely both nodular and infiltrative BCC, the patient was diagnosed as having linear BCC.
Discussion
In 2011, Al-Niaimi and Lyon analyzed 37 reported cases of linear BCC retrieved in an exhaustive literature search [3] . In all of the cases described, linear BCC appeared to extend preferentially in one direction, resulting in a characteristic morphology of a linear lesion with straight edges and a length much longer than the width (with a ratio of at least 3:1). From their review of those cases, Al-Niaimi and Lyon made the following observations about linear BCC: (1) the most frequently affected sites are the periorbital area and the neck (68%), and (2) tumor cell infiltration (subclinical extension) is more easily seen than the clinical lesion. Al-Niaimi and Lyon concluded that linear BCC should be considered a distinct clinical morphological variant of BCC [3] .
From our findings, we believe that this subtype of BCC is genuinely rare, but may be underreported due to its underrecognition as a distinct presentation of BCC [4] . The clinical manifestation of this disease as a linear form may be due to the fact that the dermis of the eyelid is thin and quite poor in fibrous components [5] ; thus, the lesion might expand along wrinkles, resulting in the linear shape [6, 7] .
We searched Japana Centra Revuo Medicina for Japanese-language reports of linear BCC. We encountered only 10 cases of linear BCC reported in Japan from 1983 to 2011 [8] [9] [10] . Including the present case, the patients consisted of 4 men and 7 women, ranging in age from 28 to 88 years (mean: 70). The duration of the lesion before excision ranged from 6 months to 20 years (mean: 6.2 years).
The most common site for linear BCC was the periocular region. The locations of linear BCC onset were the lower eyelid (4 cases), underneath the eyebrow (1 case), nasolabial groove (1 case), and the forehead (1 case). In the remaining 4 patients with linear BCC, the lesion was found on the axilla (2 cases), the palm (1 case), or the inguinal region (1 case). In all cases, the tumor appeared clinically as a linear lesion along a wrinkle. Histopathological classifications included solid type (4 cases), solid + superficial type (2 cases), and superficial type (1 case). Histologic subtypes were not reported in the remaining 4 cases. None of the tumors were classified as morphemic (a high-risk type), and tumor recurrence was not observed in any of the cases reported in Japan.
In patients with small nodules assuming a linear form around the eyes, linear BCC should be considered in the differential diagnosis. In treating linear BCC, it is essential to resect the lesion carefully to prevent tumor recurrence, bearing in mind that subclinical extension of tumor cells is sometimes more extensive than the clinical lesion. 
